Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.

Kickingerede P, Brugnara G, Hansen MB, et al. Radiology. 2020;200978

Our unique biomarkers were used in a study to evaluate the effectiveness of the bevacizumab treatment.

Get full access to the article doi:

Click Here

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
Contact us
Cercare Medical A/S
Inge Lehmanns Gade 10
8000 Aarhus C
Denmark

Solutions
Cercare Perfusion Neuro & Oncology Stroke Modules
Support
Assistance Instructions for Use
Company
Board Members Investors About News Privacy Policy Regulatory & Compliance
© 2024 Cercare Medical. All rights reserved.
TRY US

CLINICAL USE CASES AND TECHNICAL HIGHLIGHTS


CBCT PERFUSION IN THE ANGIO SUITE
CBCT Perfusion delivers CT-quality perfusion maps directly in the angio suite,
using standard C-arm systems. For the first time, clinicians can access
advanced tissue insights without interrupting care or delaying treatment.

CLINICAL USE CASES
  • Assess outcomes post-intervention: detect missed stenoses, distal occlusions, or microvascular disturbances.
  • Guide complementary therapies on the spot based on perfusion status.
  • May detect the no-reflow phenomenon — providing insight into cases where recovery may fail despite successful thrombectomy.
  • Potentially enables direct-to-angio workflows.

TECHNICAL HIGHLIGHTS
  • Full set of perfusion markers: CBF, CBV, MTT.
  • Advanced oxygen metabolism imaging: OEF, CMRO₂.
  • Reliable results with as few as 5 CBCT acquisitions (bolus injection timing protocol very important).
  • Integrated with Siemens and Philips systems; GE/Canon under evaluation.

CBCT Imaging

Side-by-side comparison: The left-hand side is the raw CBCT data, while the right-hand side panel is the pre-processed data.
Using CMN software in the angio suite delivers results comparable to conventional CT/MR perfusion.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.
Perfusion Summit 2026
Date: 26 March 2026, Thursday
Time: 10:15 - 17:40 (CET)
Venue: Concorde Hall, Hilton Paris Hotel, CDG
Participation is Optional

Hands-On Workshops
Date: 27 March 2026

Workshop selection is optional and does not confirm registration. Confirmation and further details will be provided in January 2026. Please note that seating is limited.
By participating in this event, you consent to the use of your image, voice, and likeness in photographs, and videos for promotional purposes, in accordance with GDPR regulations.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)



    Request a demo

    Let us give you a tour around our solution.

    Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.



      })